The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Regulatory News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: -0.25 (-2.50%)
Spread: 0.50 (5.263%)
Open: 10.15
High: 10.15
Low: 9.75
Prev. Close: 10.00
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Jun 2017 10:38

RNS Number : 6698H
SkinBioTherapeutics PLC
09 June 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

SkinBioTherapeutics

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

NO

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

NO

An event changing the breakdown of voting rights

NO

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

SPREADEX LTD

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

30/05/2017

6. Date on which issuer notified:

08/06/2017

7. Threshold(s) that is/are crossed orreached: vi, vii

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary 1 -

3,233,333

3,233,333

2,933,333

2,933,333

2.47%

GB00BF33H870

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

CFD/SPREADBET

501,445

0.42%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,434,778

2.89%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

DAVID CORBEN

15. Contact telephone number:

01727 895135

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFLMLTMBJMMFR
Date   Source Headline
29th May 20187:00 amRNSSkinBioTherapeutics involved in new research grant
14th May 20187:00 amRNSSkinBioTherapeutics files new patent application
1st May 20187:00 amRNSSkinBioTherapeutics plans for human study
24th Apr 20188:56 amRNSHolding(s) in Company
17th Apr 20187:00 amRNSPositive cream formulation results for SkinBiotix
3rd Apr 20187:00 amRNSSBTX signs MTA with global consumer goods company
21st Feb 20187:00 amRNSHalf year results
16th Feb 201810:02 amRNSNotice of Interim Results
5th Jan 20187:00 amRNSAppointment of Joint Broker
1st Dec 20177:05 amRNSNotification of first patent grant
9th Nov 20177:00 amRNSSkinBiotix platform passes external toxicity tests
8th Nov 201711:32 amRNSSkinBioTherapeutics to present at investor evening
30th Oct 201711:23 amRNSResult of AGM
5th Oct 20177:00 amRNSFinal Results
3rd Oct 20177:00 amRNSCytotoxicity results and scientific update
27th Sep 20179:00 amRNSNotice of Results
12th Sep 20178:54 amRNSHolding(s) in Company
19th Jun 20179:00 amRNSSkinBioTherapeutics to Present at Investor Evening
9th Jun 201710:38 amRNSHolding(s) in Company
23rd May 20173:21 pmRNSHolding(s) in Company
23rd May 20177:00 amRNSExtension of Research Contract
5th Apr 20177:00 amRNSFirst day of dealings - to trade under SBTX ticker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.